Kiromic Biopharma

General Information

We are a target discovery and gene editing company utilizing artificial intelligence and our proprietary neural network platform with a therapeutic focus on immuno-oncology. Our proprietary target discovery engine is called “Diamond.”

Diamond is a computational platform and a neural network that can identify new cancer immunological targets for T cells and B cells. Diamond is an artificial intelligence bioinformatic approach that can identify novel surface tumor targets. It uses public and proprietary samples and can expand into the tumor target space.

Employees: 11
Founded: 2006
Contact Information
Address 7707 Fannin, Suite 140, Houston, TX 77054, US
Phone Number (832) 968-4888
Web Address
View Prospectus: Kiromic Biopharma
Financial Information
Market Cap
Revenues $0 mil (last 12 months)
Net Income $-3.73 mil (last 12 months)
IPO Profile
Symbol KRBP
Exchange NYSE - American
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $20.0 mil
Manager / Joint Managers ThinkEquity (a division of Fordham Financial Management)
CO-Managers -
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change